XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 2,414 $ 1,498
Marketable securities 3,935 3,981
Trade and other receivables, net 396 342
Loans and merchant cash advances, net 1,733 1,224
Other current assets 227 209
Total current assets 8,705 7,254
Long-term assets    
Property and equipment, net 51 47
Operating lease right-of-use assets, net 94 93
Intangible assets, net 33 22
Deferred tax assets 29 37
Other long-term assets 23 21
Long-term investments 676 709
Equity and other investments ($3,389 and $3,930, carried at fair value) 4,363 4,647
Equity method investment 574 642
Goodwill 491 452
Total long term assets 6,334 6,670
Total assets 15,039 13,924
Current liabilities    
Accounts payable and accrued liabilities 974 737
Deferred revenue 300 283
Operating lease liabilities 19 18
Convertible senior notes 920 918
Total current liabilities 2,213 1,956
Long-term liabilities    
Deferred revenue 110 147
Operating lease liabilities 176 190
Deferred tax liabilities 29 73
Total long term liabilities 315 410
Contingencies (Note 11)
Equity, Attributable to Parent [Abstract]    
Common stock, unlimited Class A subordinate voting shares authorized, 1,222,039,069 and 1,215,229,233, issued and outstanding; unlimited Class B restricted voting shares authorized, 79,241,982 and 79,350,906 issued and outstanding; 1 Founder share authorized, 1 and 1 issued and outstanding 10,123 9,634
Additional paid-in capital 272 305
Accumulated other comprehensive loss (1) (10)
Accumulated surplus 2,117 1,629
Total shareholders’ equity 12,511 11,558
Total liabilities and shareholders’ equity $ 15,039 $ 13,924